Piolax, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2020 and Year Ending March 31, 2020; Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2020
August 18, 2019
Share
Piolax, Inc. reported consolidated earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported net sales of JPY 15,896 million compared to JPY 17,160 million a year ago. Operating income was JPY 1,721 million compared to JPY 2,598 million a year ago. Net income attributable to owners of the company was JPY 1,545 million or JPY 43.15 per share compared to JPY 2,186 million or JPY 61.05 per share a year ago.
The company provided consolidated earnings guidance for the first half of fiscal year 2020 and year ending March 31, 2020. For the first half, the company expects net sales of JPY 32,600 million, operating income of JPY 3,800 million and net income of JPY 3,000 million or JPY 83.76 per share.
For the year ending March 31, 2020, the company expects net sales of JPY 66,000 million, operating income of JPY 8,000 million and net income of JPY 6,200 million or JPY 173.11 per share.
For the fiscal year 2020, the company expects second quarter dividend of JPY 22.50 per share against JPY 22.50 per share a year ago.
For the fiscal year ending March 31, 2020, the company expects year-end dividend of JPY 22.50 per share against JPY 22.50 per share a year ago.
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Piolax, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2020 and Year Ending March 31, 2020; Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2020